IQI
PCRX icon

Integrated Quantitative Investments’s Pacira BioSciences PCRX Stock Holding History

Integrated Quantitative Investments’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-64,826
Closed -$1.68M – 513
2025
Q4 		$1.68M Buy
+64,826
New +$1.54M 0.36% 71
2025
Q3 		– Sell
-10,379
Closed -$248K – 433
2025
Q2 		$248K Sell
10,379
-28,621
-73% -$721K 0.07% 340
2025
Q1 		$969K Sell
39,000
-147
-0.4% -$3.52K 0.48% 74
2024
Q4 		$738K Buy
+39,147
New +$687K 0.36% 116

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Integrated Quantitative Investments's PCRX Position: Q1 2026 in Review

Integrated Quantitative Investments sold out of Pacira BioSciences (PCRX) in Q1 2026, closing a stake of 64,826 shares — an estimated $1.68M sold.

Integrated Quantitative Investments first reported a position in PCRX in Q4 2024 and held it in 4 quarters. The position peaked at $1.68M in Q4 2025. 242 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Integrated Quantitative Investments reported no remaining Pacira BioSciences position as of Q1 2026 after selling out during the quarter.
  • Integrated Quantitative Investments sold 64,826 Pacira BioSciences shares in Q1 2026, an estimated $1.68M.
  • Integrated Quantitative Investments first reported a position in Pacira BioSciences in Q4 2024 and held it in 4 quarters.
  • Integrated Quantitative Investments's Pacira BioSciences position peaked at $1.68M in Q4 2025.
  • 242 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Integrated Quantitative Investments's 13F filing for Q1 2026, filed 13 May 2026.